Antibody-dependent enhancement of dengue virus infection inhibits RLR-mediated Type-I IFNindependent signalling through upregulation of cellular autophagy

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Huang, Xinwei ^a,b   Yue, Yaofei ^a   Li, Duo ^a   Zhao, Yujiao ^a   Qiu, Lijuan ^a   Chen, Junying ^a   Pan, Yue ^a   Xi, Juemin ^a   Wang, Xiaodan ^a   Sun, Qiangming ^a   Li, Qihan ^a  

^a INSTITUTE OF MEDICAL BIOLOGY   (China)

^b Key Laboratory of the Second Affiliated Hospital of Kuming Medical College   (China)

Author keywords

[No Author keywords available]

Indexed keywords

(S)-1-(4-METHYL-1-(2-PYRIMIDINYL)-4-PIPERIDYLAMINO)ACETYL-2-PYRROLIDINECARBONITRILE; DDX58 PROTEIN, HUMAN; IFIH1 PROTEIN, HUMAN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERFERON; INTERFERON INDUCED HELICASE C DOMAIN CONTAINING PROTEIN 1; INTERLEUKIN 10; NEUTRALIZING ANTIBODY; NITRILE; PYRROLIDINE DERIVATIVE; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR; VIRUS ANTIBODY; VIRUS RNA;

AUTOPHAGY; BIOSYNTHESIS; CELL LINE; DENGUE; DENGUE VIRUS; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; UPREGULATION; VIROLOGY; VIRUS LOAD; VIRUS REPLICATION;

ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; AUTOPHAGY; CELL LINE; DEAD BOX PROTEIN 58; DENGUE; DENGUE VIRUS; GENE EXPRESSION; HUMANS; IMMUNITY, INNATE; INTERFERON TYPE I; INTERFERON-INDUCED HELICASE, IFIH1; INTERLEUKIN-10; NITRIC OXIDE SYNTHASE TYPE II; NITRILES; PYRROLIDINES; RNA, VIRAL; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; UP-REGULATION; VIRAL LOAD; VIRUS REPLICATION;

EID: 84988614164     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep22303     Document Type: Article

References (60)

1. Simmons, C. P., Farrar, J. J., Nguyen v, V. & Wills, B. Dengue. The New England journal of medicine 366, 1423-1432, doi: 10.1056/NEJMra1110265 (2012).
2. Eisen, L. & Lozano-Fuentes, S. Use of mapping and spatial and space-time modeling approaches in operational control of Aedes aegypti and dengue. PLoS neglected tropical diseases 3, e411, doi: 10.1371/journal.pntd.0000411 (2009).
3. Rodenhuis-Zybert, I. A., Wilschut, J. & Smit, J. M. Dengue virus life cycle: viral and host factors modulating infectivity. Cellular and molecular life sciences: CMLS 67, 2773-2786, doi: 10.1007/s00018-010-0357-z (2010).
4. Kliks, S. C., Nimmanitya, S., Nisalak, A. & Burke, D. S. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. The American journal of tropical medicine and hygiene 38, 411-419 (1988).
5. Jessie, K., Fong, M. Y., Devi, S., Lam, S. K. & Wong, K. T. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. The Journal of infectious diseases 189, 1411-1418, doi: 10.1086/383043 (2004).
6. Balsitis, S. J. et al. Tropism of dengue virus in mice and humans defined by viral nonstructural protein 3-specific immunostaining. The American journal of tropical medicine and hygiene 80, 416-424 (2009).
7. Boonnak, K., Dambach, K. M., Donofrio, G. C., Tassaneetrithep, B. & Marovich, M. A. Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection. Journal of virology 85, 1671-1683, doi: 10.1128/JVI.00220-10 (2011).
8. Rodenhuis-Zybert, I. A. et al. Immature dengue virus: a veiled pathogen? PLoS pathogens 6, e1000718, doi: 10.1371/journal. ppat.1000718 (2010).
9. Balsitis, S. J. et al. Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PLoS pathogens 6, e1000790, doi: 10.1371/journal.ppat.1000790 (2010).
10. Goncalvez, A. P., Engle, R. E., St Claire, M., Purcell, R. H. & Lai, C. J. Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention. Proceedings of the National Academy of Sciences of the United States of America 104, 9422-9427, doi: 10.1073/pnas.0703498104 (2007).
11. Green, S. et al. Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. Journal of medical virology 59, 329-334 (1999).
12. Chareonsirisuthigul, T., Kalayanarooj, S. & Ubol, S. Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells. The Journal of general virology 88, 365-375, doi: 10.1099/vir.0.82537-0 (2007).
13. Ubol, S., Phuklia, W., Kalayanarooj, S. & Modhiran, N. Mechanisms of immune evasion induced by a complex of dengue virus and preexisting enhancing antibodies. The Journal of infectious diseases 201, 923-935, doi: 10.1086/651018 (2010).
14. Rolph, M. S., Zaid, A., Rulli, N. E. & Mahalingam, S. Downregulation of interferon-β in antibody-dependent enhancement of dengue viral infections of human macrophages is dependent on interleukin-6. Journal of Infectious Diseases 204, 489-491 (2011).
15. Tsai, T. T. et al. An emerging role for the anti-inflammatory cytokine interleukin-10 in dengue virus infection. J Biomed Sci 20, 40, doi: 10.1186/1423-0127-20-40 (2013).
16. Kou, Z. et al. Human antibodies against dengue enhance dengue viral infectivity without suppressing type I interferon secretion in primary human monocytes. Virology 410, 240-247, doi: 10.1016/j.virol.2010.11.007 (2011).
17. Jin, X., Block, O. T., Rose, R. & Schlesinger, J. Dengue vaccine development and dengue viral neutralization and enhancement assays. Antivir Ther 14, 739-749 (2009).
18. Moi, M. L., Takasaki, T., Saijo, M. & Kurane, I. Determination of antibody concentration as the main parameter in a dengue virus antibody-dependent enhancement assay using FcgammaR-expressing BHK cells. Archives of virology 159, 103-116, doi: 10.1007/s00705-013-1787-3 (2014).
19. Boonnak, K., Slike, B. M., Donofrio, G. C. & Marovich, M. A. Human FcgammaRII cytoplasmic domains differentially influence antibody-mediated dengue virus infection. Journal of immunology 190, 5659-5665, doi: 10.4049/jimmunol.1203052 (2013).
20. Valero, N., Espina, L. M., Anez, G., Torres, E. & Mosquera, J. A. Short report: increased level of serum nitric oxide in patients with dengue. The American journal of tropical medicine and hygiene 66, 762-764 (2002).
21. Takhampunya, R., Padmanabhan, R. & Ubol, S. Antiviral action of nitric oxide on dengue virus type 2 replication. The Journal of general virology 87, 3003-3011, doi: 10.1099/vir.0.81880-0 (2006).
22. Diaz, M. O. et al. Homozygous deletion of the alpha-and beta 1-interferon genes in human leukemia and derived cell lines. Proceedings of the National Academy of Sciences 85, 5259-5263 (1988).
23. Yoneyama, M., Onomoto, K., Jogi, M., Akaboshi, T. & Fujita, T. Viral RNA detection by RIG-I-like receptors. Current opinion in immunology 32, 48-53 (2015).
24. Halstead, S. B., Mahalingam, S., Marovich, M. A., Ubol, S. & Mosser, D. M. Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. The Lancet infectious diseases 10, 712-722 (2010).
25. Chan, K. R. et al. Leukocyte immunoglobulin-like receptor B1 is critical for antibody-dependent dengue. Proceedings of the National Academy of Sciences 111, 2722-2727 (2014).
26. De Vera, M. E. et al. Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter. Proceedings of the National Academy of Sciences 93, 1054-1059 (1996).
27. Lowenstein, C. J. & Padalko, E. iNOS (NOS2) at a glance. Journal of cell science 117, 2865-2867 (2004).
28. Hung, N. T. et al. Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. Journal of infectious Diseases 189, 221-232 (2004).
29. Richards, A. L. & Jackson, W. T. How positive-strand RNA viruses benefit from autophagosome maturation. Journal of virology 87, 9966-9972, doi: 10.1128/jvi.00460-13 (2013).
30. Jounai, N. et al. The Atg5-Atg12 conjugate associates with innate antiviral immune responses. Proceedings of the National Academy of Sciences 104, 14050-14055 (2007).
31. Zhao, Y. et al. COX5B regulates MAVS-mediated antiviral signaling through interaction with ATG5 and repressing ROS production. PLoS pathogens 8, e1003086 (2012).
32. Mahalingam, S. & Lidbury, B. A. Suppression of lipopolysaccharide-induced antiviral transcription factor (STAT-1 and NF-κ B) complexes by antibody-dependent enhancement of macrophage infection by Ross River virus. Proceedings of the National Academy of Sciences 99, 13819-13824 (2002).
33. Schoggins, J. W. et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472, 481-485 (2011).
34. Pulit-Penaloza, J. A., Scherbik, S. V. & Brinton, M. A. Type 1 IFN-independent activation of a subset of interferon stimulated genes in West Nile virus Eg101-infected mouse cells. Virology 425, 82-94 (2012).
35. Olagnier, D. et al. Inhibition of dengue and chikungunya virus infections by RIG-I-mediated type I interferon-independent stimulation of the innate antiviral response. Journal of virology 88, 4180-4194 (2014).
36. Dixit, E. et al. Peroxisomes are signaling platforms for antiviral innate immunity. Cell 141, 668-681 (2010).
37. Paladino, P., Cummings, D. T., Noyce, R. S. & Mossman, K. L. The IFN-independent response to virus particle entry provides a first line of antiviral defense that is independent of TLRs and retinoic acid-inducible gene I. The Journal of Immunology 177, 8008-8016 (2006).
38. Flipse, J., Wilschut, J. & Smit, J. M. Molecular mechanisms involved in antibody-dependent enhancement of dengue virus infection in humans. Traffic 14, 25-35, doi: 10.1111/tra.12012 (2013).
39. Dhodapkar, K. M. et al. Selective blockade of the inhibitory Fcγ receptor (Fcγ RIIB) in human dendritic cells and monocytes induces a type I interferon response program. The Journal of experimental medicine 204, 1359-1369 (2007).
40. Khor, C. C. et al. Genome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1. Nature genetics 43, 1139-1141 (2011).
41. Callaway, J. B. et al. Spleen Tyrosine Kinase (Syk) Mediates IL-1β Induction by Primary Human Monocytes During Antibody-Enhanced Dengue Virus Infection. Journal of Biological Chemistry 290, 17306-17320 (2015).
42. Chen, L. C. et al. Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. The American journal of tropical medicine and hygiene 74, 142-147 (2006).
43. Libraty, D. H. et al. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. Journal of Infectious Diseases 185, 1213-1221 (2002).
44. Malavige, G. N. et al. Suppression of virus specific immune responses by IL-10 in acute dengue infection. PLoS neglected tropical diseases 7, e2409, doi: 10.1371/journal.pntd.0002409 (2013).
45. Tsai, T. T. et al. Antibody-dependent enhancement infection facilitates dengue virus-regulated signaling of IL-10 production in monocytes. PLoS neglected tropical diseases 8, e3320, doi: 10.1371/journal.pntd.0003320 (2014).
46. Yoneyama, M. et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nature immunology 5, 730-737, doi: 10.1038/ni1087 (2004).
47. Jones, M. et al. Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression. Journal of virology 79, 5414-5420, doi: 10.1128/JVI.79.9.5414-5420.2005 (2005).
48. Munoz-Jordan, J. L. et al. Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. Journal of virology 79, 8004-8013 (2005).
49. Munoz-Jordan, J. L., Sanchez-Burgos, G. G., Laurent-Rolle, M. & Garcia-Sastre, A. Inhibition of interferon signaling by dengue virus. Proceedings of the National Academy of Sciences 100, 14333-14338 (2003).
50. Aguirre, S. et al. DENV inhibits type I IFN production in infected cells by cleaving human STING. PLoS pathogens 8, e1002934 (2012).
51. Jackson, W. T. Viruses and the autophagy pathway. Virology 479, 450-456 (2015).
52. Khakpoor, A., Panyasrivanit, M., Wikan, N. & Smith, D. R. A role for autophagolysosomes in dengue virus 3 production in HepG2 cells. Journal of General Virology 90, 1093-1103 (2009).
53. Mateo, R. et al. Inhibition of cellular autophagy deranges dengue virion maturation. Journal of virology 87, 1312-1321 (2013).
54. Panyasrivanit, M. et al. Induced autophagy reduces virus output in dengue infected monocytic cells. Virology 418, 74-84 (2011).
55. Panyasrivanit, M., Khakpoor, A., Wikan, N. & Smith, D. R. Co-localization of constituents of the dengue virus translation and replication machinery with amphisomes. Journal of General Virology 90, 448-456 (2009).
56. Jackson, W. T. et al. Subversion of cellular autophagosomal machinery by RNA viruses. PLoS biology 3, e156 (2005).
57. Yorimitsu, T. & Klionsky, D. J. Endoplasmic reticulum stress:a new pathway to induce autophagy. Autophagy 3, 160-162 (2007).
58. Tal, M. C. et al. Absence of autophagy results in reactive oxygen species-dependent amplification of RLR signaling. Proceedings of the National Academy of Sciences of the United States of America 106, 2770-2775, doi: 10.1073/pnas.0807694106 (2009).
59. Huang, J. et al. Activation of antibacterial autophagy by NADPH oxidases. Proceedings of the National Academy of Sciences 106, 6226-6231 (2009).
60. Brooks, C. R. et al. KIM- 1-/TIM- 1- mediated phagocytosis links ATG5-/ULK1-dependent clearance of apoptotic cells to antigen presentation. The EMBO journal e201489838 (2015).